Itron Stock Story


USD 52.80  0.20  0.38%   

Today we may see the proof that Cognex Cp would recover slower from the current slide as its shares fell 3.14% to Itron's 1.63%. As many rational traders are trying to avoid technology space, it makes sense to concentrate on Itron Inc a little further and understand how it stands against Cognex Cp and other similar entities. We are going to examine some of the competitive aspects of both Itron and Cognex.
Published over three months ago
View all stories for Itron | View All Stories

Will Itron (NASDAQ:ITRI) shadow Cognex Cp price jump?

By analyzing existing basic indicators between Itron and Cognex, you can compare the effects of market volatilities on both companies' prices and check if they can diversify away market risk if combined in one of your portfolios. You can also utilize pair trading strategies for matching a long position in Cognex with a short position in Itron. Check out our pair correlation module for more information.

Let's begin by analyzing the assets.
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Itron has an asset utilization ratio of 817.0 percent. This implies that the company is making $8.17 for each dollar of assets. An increasing asset utilization means that Itron Inc is more efficient with each dollar of assets it utilizes for everyday operations.

How important is Itron's Liquidity

Itron financial leverage refers to using borrowed capital as a funding source to finance Itron Inc ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Itron financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Itron's total debt and its cash.

What do experts say?

Stock analysis is a method for investors and traders to make buying and selling decisions. By studying and evaluating past and current data, investors and traders attempt to gain an edge in the markets by making informed decisions.
It is good to see analyst projects for Itron, but it might be worth checking our own buy vs. sell analysis

Sale by Marcolini John F of 199 shares of Itron

Legal trades by Itron insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
Itron insider trading alert for sale of common stock by Marcolini John F, SVP Networked Solutions, on 6th of July 2022. This event was filed by Itron Inc with SEC on 2022-07-06. Statement of changes in beneficial ownership - SEC Form 4 [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

A Deeper Perspective

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

Revenue Breakdown

Let me take a closer look at Itron revenue. Based on the latest financial disclosure, Itron Inc reported 2.02 B of revenue. This is 50.44% lower than that of the Technology sector and 69.74% higher than that of the Scientific & Technical Instruments industry. The revenue for all United States stocks is 78.59% higher than that of Itron Inc. As for Cognex Cp we see revenue of 1.02 B, which is 14.29% lower than that of the Scientific & Technical Instruments

Itron2.02 Billion
Sector1.19 Billion
Cognex1.02 Billion
1.2 B

Another setback for Itron stockholders

Current coefficient of variation is at -1148.66. Itron Inc exhibits very low volatility with skewness of -0.97 and kurtosis of 3.49. However, we advise investors to further study Itron Inc technical indicators to make sure all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Itron's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Itron's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Itron Implied Volatility

Itron's implied volatility exposes the market's sentiment of Itron Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Itron's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Itron stock will not fluctuate a lot when Itron's options are near their expiration.

Our Takeaway on Itron Investment

While some other firms in the scientific & technical instruments industry are either recovering or due for a correction, Itron may not be performing as strong as the other in terms of long-term growth potentials. To conclude, as of the 1st of May 2022, our research shows that Itron is a rather very steady investment opportunity with a very low odds of financial turmoil in the next two years. From a slightly different view, the entity currently appears to be undervalued. Our latest 90 days buy vs. sell advice on the company is Strong Hold.

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of Itron Inc. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to